The LRP Presents the Fiscal Year 2021 Transformative Vision Award Recipient
Posted August 4, 2023
Megan E.B. Clowse, M.D., M.P.H., Duke University
Patients with systemic lupus erythematosus (SLE) experience a range of symptoms that can severely impact quality of life, such as fatigue, chronic pain, and brain fog. Currently, the causal link between inflammation and these symptoms is unclear and can complicate disease management for both patients and physicians. Dr. Clowse, in partnership with Drs. Jennifer Rogers, David Pisetsky, and Amanda Eudy, have classified SLE symptoms into two categories: type 1, which includes autoimmune inflammation of tissues (arthritis, cutaneous lupus, lupus nephritis) and type 2, which are essential features of SLE but have unknown causes (brain fog, myalgia, and fatigue). Furthermore, type 2 symptoms are divided by how they present, as either intermittent (type 1 and type 2 symptoms appear at the same time) or persistent (type 2 symptoms persist without type 1 symptoms). With a fiscal year 2021 Lupus Research Program Transformative Vision Award, Dr. Clowse and her research team will develop and test the Whole Health Empowerment for Endotypes of Lupus (WHEEL) program, which is a group-based health-coach led program with two distinct curricula, one for intermittent type 2 SLE and the other for persistent type 2 symptoms. These programs will be developed in close collaboration with patient partners to ensure they meet the unique needs of people living with SLE. This program has the potential to improve quality of life for SLE patients by empowering them to take control of their health.
Last updated Friday, August 4, 2023